Edition:
United Kingdom

Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

69.11USD
17 May 2019
Change (% chg)

$-0.19 (-0.27%)
Prev Close
$69.30
Open
$68.27
Day's High
$69.86
Day's Low
$68.27
Volume
690,865
Avg. Vol
491,073
52-wk High
$82.26
52-wk Low
$60.46

Latest Key Developments (Source: Significant Developments)

Agilent Technologies Reports Q2 Earnings Per Share $0.57
Tuesday, 14 May 2019 

May 14 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES REPORTS SECOND QUARTER FISCAL YEAR 2019 FINANCIAL RESULTS.SEES Q3 2019 NON-GAAP EARNINGS PER SHARE $0.71 TO $0.73.Q2 NON-GAAP EARNINGS PER SHARE $0.71.Q2 EARNINGS PER SHARE $0.57.SEES Q3 2019 REVENUE $1.225 BILLION TO $1.245 BILLION.Q2 REVENUE $1.24 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.27 BILLION.Q2 EARNINGS PER SHARE ESTIMATE $0.72 -- REFINITIV IBES DATA.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $3.03 TO $3.07.SEES FY 2019 REVENUE $5.085 BILLION TO $5.125 BILLION.Q3 EARNINGS PER SHARE VIEW $0.73, REVENUE VIEW $1.27 BILLION -- REFINITIV IBES DATA.FY2019 EARNINGS PER SHARE VIEW $3.07, REVENUE VIEW $5.19 BILLION -- REFINITIV IBES DATA.  Full Article

Agilent Receives An Expanded FDA Approval For Its Companion Diagnostic In NSCLC
Wednesday, 17 Apr 2019 

April 16 (Reuters) - Agilent Technologies Inc ::AGILENT RECEIVES AN EXPANDED FDA APPROVAL FOR ITS COMPANION DIAGNOSTIC IN NSCLC.U.S. FOOD AND DRUG ADMINISTRATION HAS UPDATED ITS APPROVAL OF COMPANY'S PD-L1 IHC 22C3 PHARMDX ASSAY.AGILENT TECHNOLOGIES - PD-L1 IHC 22C3 PHARMDX CAN NOW BE USED TO IDENTIFY A BROADER RANGE OF NSCLC PATIENTS FOR FIRST-LINE TREATMENT WITH KEYTRUDA.  Full Article

Agilent Technologies Announces Cash Dividend Of 16.4 Cents Per Share
Wednesday, 20 Mar 2019 

Agilent Technologies Inc ::AGILENT TECHNOLOGIES ANNOUNCES CASH DIVIDEND OF 16.4 CENTS PER SHARE.  Full Article

Agilent Technologies Inc Enters Into A Credit Agreement
Wednesday, 13 Mar 2019 

March 13 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES INC - ENTERED INTO A CREDIT AGREEMENT THAT PROVIDES FOR A $1 BILLION FIVE-YEAR, UNSECURED CREDIT FACILITY.AGILENT TECHNOLOGIES INC - CREDIT FACILITY WILL MATURE ON MARCH 13, 2024.AGILENT TECHNOLOGIES INC - FACILITY REPLACED COMPANY S EXISTING CREDIT FACILITY, WHICH WAS TERMINATED ON CLOSING DATE OF FACILITY.  Full Article

Agilent Technologies Reports First-Quarter Fiscal Year 2019 Financial Results
Wednesday, 20 Feb 2019 

Feb 20 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES REPORTS FIRST-QUARTER FISCAL YEAR 2019 FINANCIAL RESULTS.SEES Q2 2019 NON-GAAP EARNINGS PER SHARE $0.70 TO $0.72.Q1 GAAP EARNINGS PER SHARE $1.57.SEES Q2 2019 REVENUE $1.255 BILLION TO $1.27 BILLION.Q1 REVENUE $1.28 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.27 BILLION.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $3.03 TO $3.07.Q1 NON-GAAP EARNINGS PER SHARE $0.76.SEES FY 2019 REVENUE $5.15 BILLION TO $5.19 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.73 -- REFINITIV IBES DATA.Q2 EARNINGS PER SHARE VIEW $0.72, REVENUE VIEW $1.27 BILLION -- REFINITIV IBES DATA.  Full Article

Jana Partners Llc Dissolves Sole Share Stake In Farfetch Ltd, SVMK Inc; Takes in Mastercard
Thursday, 14 Feb 2019 

Feb 14 (Reuters) - Jana Partners LLC::JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN AGILENT TECHNOLOGIES INC - SEC FILING.JANA PARTNERS LLC TAKES SOLE SHARE STAKE OF 80,000 CLASS A COMMON SHARES IN MASTERCARD INC.JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN SVMK INC.JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN ZOETIS INC.JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN FARFETCH LTD.JANA PARTNERS LLC TAKES SOLE SHARE STAKE OF 125,000 COMMON SHARES IN WILLSCOT CORP.JANA PARTNERS LLC DISSOLVES SOLE SHARE STAKE IN KEURIG DR PEPPER INC.JANA PARTNERS LLC - CHANGE IN HOLDINGS ARE AS OF DECEMBER 31, 2018 AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF SEPTEMBER 30, 2018.  Full Article

Agilent Technologies Says CEO FY18 Total Compensation $11.7 Mln Vs $10.1 Mln In FY17
Thursday, 7 Feb 2019 

Feb 7 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES INC SAYS CEO MICHAEL MCMULLEN'S FY 2018 TOTAL COMPENSATION WAS $11.7 MILLION VERSUS $10.1 MILLION IN FY 2017 - SEC FILING.  Full Article

Agilent Sends Letter To SEC About "Misstatements" In Twist Bioscience’s S-1
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Agilent Technologies Inc ::AGILENT SENDS LETTER TO THE SEC REGARDING MATERIAL MISSTATEMENTS IN TWIST BIOSCIENCE’S S-1 REGISTRATION STATEMENT.AGILENT - LETTER INFORMS THAT “TWIST’S S-1 FAILS TO DISCLOSE THAT TWIST CEO EMILY LEPROUST FORMED TWIST WHILE AN EMPLOYEE AT AGILENT".AGILENT - LEPROUST ADMITTED UNDER OATH THAT SHE "SECRETLY BECAME TWIST’S CEO 17 MONTHS PRIOR TO LEAVING AGILENT".AGILENT, IN LETTER TO SEC - TWIST'S S-1 DOES NOT DISCLOSE FACT THAT CEO, EMPLOYEES RETAINED CONFIDENTIAL DOCUMENTS WITH CO'S TRADE SECRETS AND PROPRIETARY INFORMATION.  Full Article

ACEA Biosciences To Be Acquired By Agilent Technologies
Wednesday, 26 Sep 2018 

Sept 26 (Reuters) - Agilent Technologies Inc ::ACEA BIOSCIENCES TO BE ACQUIRED BY AGILENT TECHNOLOGIES.ACEA BIOSCIENCES - SIGNED A DEFINITIVE AGREEMENT TO JOIN AGILENT TECHNOLOGIES, INC.  Full Article

Agilent Technologies Signs Definitive Agreement To Acquire ACEA Biosciences For $250 Mln
Wednesday, 26 Sep 2018 

Sept 25 (Reuters) - Agilent Technologies Inc ::AGILENT TO EXPAND PORTFOLIO AND CAPABILITIES IN CELL ANALYSIS WITH ACQUISITION OF ACEA BIOSCIENCES.AGILENT TECHNOLOGIES- SIGNED A DEFINITIVE AGREEMENT TO ACQUIRE PRIVATELY-OWNED ACEA BIOSCIENCES INC FOR $250 MILLION IN CASH.  Full Article